• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脊柱肿瘤治疗相关费用的变异性:美国国家癌症研究所指定癌症中心的支付方协商费率比较。

Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.

机构信息

Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, East Providence, RI, 02914, USA.

Department of Orthopedic Surgery, Warren Alpert Medical School of Brown University, 1 Kettle Point Ave, East Providence, RI, 02914, USA.

出版信息

Spine J. 2024 Feb;24(2):304-309. doi: 10.1016/j.spinee.2023.10.008. Epub 2023 Oct 29.

DOI:10.1016/j.spinee.2023.10.008
PMID:38440969
Abstract

BACKGROUND

As of 2021, the Centers for Medicare and Medicaid Services (CMS) requires all hospitals to publish their commercially negotiated prices. To our knowledge, price variation of spine oncology diagnosis and treatments has not been previously investigated.

PURPOSE

The aim of this study is to characterize the availability and variation of prices for spinal oncology services among National Cancer Institute-Designated Cancer Centers (NCI-DCC).

STUDY DESIGN

Cross-sectional analysis.

METHODS

Cancer centers were identified; those that did not provide patient care or participate in Medicare's Inpatient Prospective System were excluded. A cross-sectional analysis was conducted to gather commercially negotiated prices by searching online for "[center name] price transparency OR machine-readable file OR chargemaster." Data obtained was queried using 44 current procedural terminology (CPT) codes for imaging, procedures, and surgeries relevant to spine oncology. Comparison of prices was achieved by normalizing the median price for each service at each center to the estimated 2022 Medicare reimbursement for the center's Medicare Administrator Contractor. The ratios between the lowest and highest median commercial negotiated price within a center and across all centers were defined as "within-center ratio" and "across-center ratio" respectively.

RESULTS

In total, 49 centers disclosed commercial payer-negotiated rates. Mean rate (±SD) for cervical corpectomy was $9,134 (±$10,034), thoracic laminectomy for neoplasm excision was $5,382 (±$5502), superficial bone biopsy was $1,853 (±$1,717), and single-photon emission computerized tomography (SPECT) was $813 (±$232). Within-center ratios ranged from 5.0 (SPECT scan) to 17.8 (radiofrequency bone ablation). Across-center ratios (for codes with > 10 centers reporting) ranged from 9.0 (corpectomy, thoracic, lateral extra-cavitary) to 418.7 (anterior approach cervical corpectomy).

CONCLUSIONS

Price transparency for spinal oncology remains elusive despite recent CMS regulatory oversight, with marked heterogeneity in the quality of published rates complicating patients' ability to "shop" for care. Additionally, there continues to be significant variation in commercial rates for spine oncology diagnosis and treatment.

CLINICAL SIGNIFICANCE

Despite regulation by CMS, prices for spinal oncology services are not uniformly available to patients and vary between NCI-DCC. The findings of this manuscript present potential barriers for patients to compare and obtain affordable care.

摘要

背景

截至 2021 年,医疗保险和医疗补助服务中心(CMS)要求所有医院公布其商业协商价格。据我们所知,脊柱肿瘤诊断和治疗的价格变化尚未得到研究。

目的

本研究旨在描述国立癌症研究所指定癌症中心(NCI-DCC)中脊柱肿瘤服务的价格可获得性和变化。

研究设计

横断面分析。

方法

确定癌症中心;那些不提供患者护理或参与医疗保险住院患者前瞻性系统的中心被排除在外。通过在线搜索“[中心名称]价格透明度或机器可读文件或收费主文件”,对商业协商价格进行了横断面分析。使用与脊柱肿瘤相关的 44 个当前程序术语 (CPT) 代码获取数据。通过将每个中心每个服务的中位数价格归一化为中心的 2022 年医疗保险报销额,来比较价格。每个中心内最低和最高中位数商业协商价格之间的比率定义为“中心内比率”,所有中心之间的比率定义为“中心间比率”。

结果

共有 49 个中心公布了商业支付方协商的费率。颈椎椎体切除术的平均费率(±SD)为$9134(±$10034),胸段椎板切除术用于肿瘤切除为$5382(±$5502),浅层骨活检为$1853(±$1717),单光子发射计算机断层扫描(SPECT)为$813(±$232)。中心内比率范围从 5.0(SPECT 扫描)到 17.8(射频骨消融)。中心间比率(对于有>10 个中心报告的代码)范围从 9.0(颈椎外侧腔外椎体切除术)到 418.7(颈椎前路椎体切除术)。

结论

尽管 CMS 最近进行了监管监督,但脊柱肿瘤的价格透明度仍然难以实现,公布的价格质量存在明显差异,这使得患者“购物”的能力变得复杂。此外,脊柱肿瘤诊断和治疗的商业费率仍然存在显著差异。

临床意义

尽管 CMS 进行了监管,但脊柱肿瘤服务的价格并未向患者普遍提供,并且在 NCI-DCC 之间存在差异。本文的研究结果为患者比较和获得负担得起的护理带来了潜在障碍。

相似文献

1
Variability in expenses related to spine oncology care: comparison of payer-negotiated rates at National Cancer Institute-Designated Cancer Centers.脊柱肿瘤治疗相关费用的变异性:美国国家癌症研究所指定癌症中心的支付方协商费率比较。
Spine J. 2024 Feb;24(2):304-309. doi: 10.1016/j.spinee.2023.10.008. Epub 2023 Oct 29.
2
Payer-Negotiated Price Variation and Relationship to Surgical Outcomes for the Most Common Cancers at NCI-Designated Cancer Centers.支付方协商价格变化与 NCI 指定癌症中心最常见癌症手术结果的关系。
Ann Surg Oncol. 2024 Jul;31(7):4339-4348. doi: 10.1245/s10434-024-15150-x. Epub 2024 Mar 20.
3
Less Than One-third of Hospitals Provide Compliant Price Transparency Information for Total Joint Arthroplasty Procedures.不到三分之一的医院提供符合要求的全膝关节置换术价格透明度信息。
Clin Orthop Relat Res. 2022 Dec 1;480(12):2316-2326. doi: 10.1097/CORR.0000000000002288. Epub 2022 Jun 24.
4
The Price-Quality Mismatch: Are Negotiated Prices for Total Joint Arthroplasty Associated With Hospital Quality in a Large California Health System?价格-质量不匹配:在加利福尼亚州的一个大型医疗体系中,全关节置换术的协商价格与医院质量有关吗?
Clin Orthop Relat Res. 2023 Jun 1;481(6):1061-1068. doi: 10.1097/CORR.0000000000002489. Epub 2022 Dec 13.
5
Evaluation of Hospital Compliance With Federal Price Transparency Regulations and Variability of Negotiated Rates for Spinal Fusion.评估医院对联邦价格透明度法规的遵守情况以及脊柱融合术议定费率的可变性。
J Am Acad Orthop Surg. 2023 Jul 1;31(13):677-686. doi: 10.5435/JAAOS-D-23-00053. Epub 2023 Apr 3.
6
Hospital-Administered Cancer Therapy Prices for Patients With Private Health Insurance.患者有私人医疗保险时医院管理的癌症疗法价格。
JAMA Intern Med. 2022 Jun 1;182(6):603-611. doi: 10.1001/jamainternmed.2022.1022.
7
Private Payer-Negotiated Prices for Outpatient Otolaryngologic Surgery.自费者协商的门诊耳鼻喉科手术价格。
Otolaryngol Head Neck Surg. 2022 Aug;167(2):262-265. doi: 10.1177/01945998211049330. Epub 2021 Sep 28.
8
Compliance With Federal Price Transparency Rules and Cost Estimation at United States Hospitals With Neurosurgical Training Programs.美国设有神经外科培训项目的医院对联邦价格透明度规则的遵守情况及成本估算
Neurosurgery. 2024 Feb 12. doi: 10.1227/neu.0000000000002858.
9
Variations in Payer-Negotiated Prices for Head and Neck Reconstructive Surgery.头颈部重建手术的支付方协商价格变化。
Otolaryngol Head Neck Surg. 2023 Nov;169(5):1154-1162. doi: 10.1002/ohn.407. Epub 2023 Jun 19.
10
Analysis of Price Transparency via National Cancer Institute-Designated Cancer Centers' Chargemasters for Prostate Cancer Radiation Therapy.通过美国国家癌症研究所指定癌症中心的收费清单分析前列腺癌放射治疗的价格透明度。
JAMA Oncol. 2020 Mar 1;6(3):409-412. doi: 10.1001/jamaoncol.2019.5690.

引用本文的文献

1
Tyrosine kinase inhibitors in Ewing's sarcoma: a systematic review.尤因肉瘤中的酪氨酸激酶抑制剂:一项系统综述。
BMC Cancer. 2025 Apr 18;25(1):735. doi: 10.1186/s12885-025-14130-y.
2
Trends in primary malignant bone cancer incidence and mortality in the United States, 2000-2017: A population-based study.2000 - 2017年美国原发性恶性骨癌发病率和死亡率趋势:一项基于人群的研究。
J Bone Oncol. 2024 May 11;46:100607. doi: 10.1016/j.jbo.2024.100607. eCollection 2024 Jun.